While influenza has two primary surface antigens, hemagglutinin (HA) and neuraminidase (NA), HA has been the focus of most antigen engineering efforts as it tends to dominate immune responses when delivered in conjunction with NA,[35, 36, 37, 38, 39] as in traditional inactivated or split virus vaccines. The gene discussed is XK; the disease is influenza.